INS and gestational diabetes: Based on this fact and the roles of SPARC in insulin resistance and obesity-related disease, we sought to examine whether circulating levels of this adipokine are altered in GDM women compared to control subjects and to investigate a potential link between levels of SPARC with clinical and biochemical measures of glucose, lipid metabolism, insulin sensitivity and inflammation in these subjects.